Open AccessAbemaciclib in Combination With Endocrine Therapy for Patients With Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer: A Phase 1b Study
Author(s) -
Sara M. Tolaney,
Muralidhar Beeram,
J. Thaddeus Beck,
Alison Conlin,
E. Claire Dees,
Shan Puhalla,
Brent N. Rexer,
Howard A. Burris,
Komal Jhaveri,
Teresa Helsten,
Carlos Becerra,
Kevin Kalinsky,
Kathleen N. Moore,
Allison M. Manuel,
Andrew Lithio,
Gregory L. Price,
Sonya C. Chapman,
Lacey M. Litchfield,
Matthew P. Goetz
Publication year - 2022
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/pbnq-vs11
Subject(s) - metastatic breast cancer , breast cancer , oncology , medicine , endocrine system , hormone receptor , her2 negative , hormone , cancer